Custom Antibodies & Affinity Binders
Revolve’s antibody discovery platform is ideal for generation of novel antibodies for research, diagnostic and therapeutic applications including bispecific antibodies, antibody-drug conjugates, and chimeric antigen receptor T cells (CAR-T).
Fast: 2-3 weeks for low nanomolar affinity (KD), 5-6 weeks for picomolar affinity
High-quality: Large libraries consisting of 100+ unique binders to multiple epitopes
Flexible: Protein, peptide, nucleic acid, and other biological and biochemical targets
Customizable: Epitope specificity, binding kinetics, scaffolds etc...